AWK vs ESPR
American Water Works (AWK) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the AWK and ESPR stock pages for the full models.
Not investment advice.